NOTICE OF RESULTS-CREO MEDICAL GROUP PLC

NOTICE OF RESULTS-CREO MEDICAL GROUP PLC

Notice of Results

 

Creo Medical Group plc (AIM: CREO), the medical device company focused on the emerging field of minimally invasive surgical endoscopy for pre-cancer and cancer patients, will announce its audited full year results for the year ended 31 December 2023 on Wednesday 15 May 2024.

 

Investor Presentation

 

Craig Gulliford, Chief Executive Officer, and Richard Rees, Chief Financial Officer, will provide a live presentation covering the full year results via the Investor Meet Company platform on Wednesday 15 May at 15:00 BST.

 

The presentation is open to all existing/potential shareholders and analysts. Questions can be submitted at any time during the live presentation.

 

Investors can sign up to Investor Meet Company at no additional cost and register in advance to meet Creo Medical Group plc via: https://www.investormeetcompany.com/creo-medical-group-plc/register-investor

 

Investors who already follow Creo Medical Group plc on the Investor Meet Company platform will automatically be invited.

No Comments

Post a Comment